Lioresal

Chronic Pain, Clonus, severe spinal cord origin Spasticity + 11 more

Treatment

20 Active Studies for Lioresal

What is Lioresal

Baclofen

The Generic name of this drug

Treatment Summary

Baclofen is a muscle relaxer that is used to relieve painful or uncomfortable muscle spasms caused by certain medical conditions. It is often prescribed to people with spinal cord injuries to reduce muscle spasticity. There is currently not enough evidence to determine whether baclofen is effective in treating alcohol withdrawal. This drug was approved by the FDA in 1992.

Lioresal

is the brand name

image of different drug pills on a surface

Lioresal Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Lioresal

Baclofen

1977

325

Effectiveness

How Lioresal Affects Patients

Baclofen is a drug that helps with muscle relaxation. It works by decreasing the amount of excitatory signals sent from pre-synaptic neurons and increasing the amount of inhibitory signals sent from post-synaptic neurons. Most commonly, it is taken orally. In one study, it was found to be more effective at reducing spasticity when given directly into the spinal cord than when taken orally. Baclofen can cause drowsiness, poor balance, slow breathing, and a decrease in heart rate. It also can help reduce pain and increase stomach acid production. Additionally, baclofen has anti-inflammatory

How Lioresal works in the body

Baclofen works by blocking signals between the brain and muscles. It binds to GABA receptors, which are found on both pre- and post-synaptic neurons. This blocks the action potentials which would normally be sent to the muscles, leading to relaxation of spasticity. It also causes an influx of potassium into the neuron, which further helps to relax the muscles. Baclofen may also act on some voltage-gated calcium channels, but the clinical significance of this is still unclear.

When to interrupt dosage

The measure of Lioresal is contingent upon the identified affliction, including Spasticity, Multiple Sclerosis and Joint Pain. The dosage is subject to the method of delivery (e.g. Injection - Intrathecal or Tablet - Oral) referenced in the table below.

Condition

Dosage

Administration

Muscle Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spinal Cord Diseases

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Multiple Sclerosis

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Clonus

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

severe spinal cord origin Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

severe cerebral origin Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Muscle Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spinal Cord Injury

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Cerebral Palsy

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Concussion

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spasm

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Alcoholism

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Muscle Rigidity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Chronic Pain

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, , Oral, Kit - Topical, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, Injection, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Warnings

Lioresal Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Baclofen may interact with Pulse Frequency

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Lioresal.

Common Lioresal Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Ethanol

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Oliceridine

Major

The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Baclofen is combined with Oliceridine.

Thalidomide

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

1,2-Benzodiazepine

Minor

Baclofen may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine.

Lioresal Toxicity & Overdose Risk

The lowest toxic dose of baclofen in rats is 145 mg/kg. Symptoms of a baclofen overdose may include confusion, sleepiness, low body temperature, shallow or slow breathing, coma, and seizures. Other rare symptoms can include changes in blood pressure, a slow or fast heartbeat, and vomiting. If someone has overdosed on baclofen, immediate medical attention should be sought. If the patient is awake, vomiting should be induced and their stomach contents should be removed. Unconscious patients should not be encouraged to vomit.

image of a doctor in a lab doing drug, clinical research

Lioresal Novel Uses: Which Conditions Have a Clinical Trial Featuring Lioresal?

451 active studies are currently investigating Lioresal's potential to reduce Clonus, Spasm and severe Spasticity of cerebral origin.

Condition

Clinical Trials

Trial Phases

Spinal Cord Injury

67 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Early Phase 1, Phase 1

Spinal Cord Diseases

10 Actively Recruiting

Not Applicable, Phase 2

Muscle Spasticity

0 Actively Recruiting

Alcoholism

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Concussion

92 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1, Phase 4

Multiple Sclerosis

114 Actively Recruiting

Phase 3, Not Applicable, Phase 4, Phase 2, Phase 1, Early Phase 1

Cerebral Palsy

0 Actively Recruiting

Chronic Pain

122 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

severe spinal cord origin Spasticity

0 Actively Recruiting

severe cerebral origin Spasticity

0 Actively Recruiting

Muscle Spasticity

0 Actively Recruiting

Clonus

0 Actively Recruiting

Spasm

0 Actively Recruiting

Muscle Rigidity

0 Actively Recruiting

Lioresal Reviews: What are patients saying about Lioresal?

4.3

Patient Review

4/21/2009

Lioresal for Muscle Spasms caused by a Spinal Disease

At first, I felt really lightheaded and confused after taking this drug. But now, I can't imagine living without it. It's made life so much easier for me.

4

Patient Review

9/23/2008

Lioresal for Muscle Spasms caused by a Spinal Disease

The medicine works quickly, but the effects don't last very long. Sometimes I have to take a few extra doses when my disease is acting up, but that's to be expected.

2.3

Patient Review

4/13/2010

Lioresal for Muscle Spasms caused by a Spinal Disease

I've been taking this medication for a month now and have yet to see any improvements. My doctor said it would help me with my muscle spasms and cramping, but I still experience those issues just as frequently.

2

Patient Review

1/1/2011

Lioresal for Abnormal Movements of Face Muscles and Tongue

I'm still having muscle spasms and my legs are painful to the touch.

1.3

Patient Review

10/19/2012

Lioresal for Muscle Spasms caused by a Spinal Disease

I've been taking this medication for a few years now, and my doctors have told me that it's the best possible option for my MS. However, I haven't seen much relief in either my facial pain or MS-related pain and stiffness.

1

Patient Review

11/4/2012

Lioresal for Muscle Spasms caused by a Spinal Disease

The very first pill caused me to sleep for an entire day, less half an hour. It also caused me to have a seizure. The doctor ordered me to take 10 mg 3x/day, but I only took one and it had these terrible effects on me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about lioresal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Lioresal make you sleepy?

"This medicine can cause symptoms like dizziness, drowsiness, vision problems, or clumsiness in some people. Be sure to know how you'll react before doing anything that could be dangerous if you're not alert, coordinated, and able to see well."

Answered by AI

What class of drug is Lioresal?

"Baclofen is a drug that is used to relax muscles and reduce spasms. It is often prescribed for people who have multiple sclerosis or spinal cord injuries. Baclofen can help to relieve muscle pain, stiffness, and spasms."

Answered by AI

Are baclofen pain killers?

"No, Baclofen is not a pain killer. It is a muscle relaxer that can help with pain caused by muscle spasms, but will not help with other types of pain."

Answered by AI

What is Lioresal used to treat?

"Lioresal is a medication that helps to relieve spasticity of voluntary muscle that is a result of disorders such as multiple sclerosis, other spinal lesions, motor neurone disease, transverse myelitis, andtraumatic partial section of the cord."

Answered by AI

Clinical Trials for Lioresal

Image of The Mind Research Network in Albuquerque, United States.

Carbon Dioxide for Traumatic Brain Injury

18 - 82
All Sexes
Albuquerque, NM

The current study tests whether different exposures to carbon dioxide (CO2) can safely result in the increased movement of proteins from the brain into the blood. The investigators believe that this would be a proxy for the brain clearing waste products more effectively. The current study will use a counter-balanced design, in which individuals with and without a history of traumatic brain injury (TBI) will receive different levels of CO2 (targeted changes of approximately 5 or 10 mmHG in end-tidal CO2) approximately one week apart. The counter-balanced design means that each participant receives a single dose of CO2 at each visit, and different doses of CO2 at each visit. The order in which participants receive the dose is randomized, and the participant will not be informed of the dose.

Recruiting
Has No Placebo

The Mind Research Network

Andrew R Mayer, Phd

Image of University of Illinois at Chicago in Chicago, United States.

Functional Balance Intervention for Multiple Sclerosis

40 - 90
All Sexes
Chicago, IL

The study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on physical and cognitive function, as well as measures of daily living among persons with multiple sclerosis (PwMS). Combined Specific Aims: Aim 1: Examine the effect of the FBI (Intervention Group) on physical function in PwMS compared to a stretching program (Control Group). Hypothesis 1: After four months of training, the FBI group will show significantly greater improvements in physical function compared to the stretching group. Aim 2: Examine the effect of the multicomponent FBI on cognitive function in PwMS compared to the stretching program. Hypothesis 2: After four months of training, the FBI group will show significantly greater improvements in cognitive function compared to the stretching group. Aim 3: Examine the effects of the multicomponent FBI compared to the Control Group among PwMS on measures of daily living (dual-task performance, balance confidence, community mobility, and quality of life). Hypothesis 3: After four months of training, the FBI group will show significantly greater improvements in measures of daily living compared to the stretching group. All assessment sessions will be conducted virtually via Zoom. All measures collected during the initial screening, pre-training assessment, training progression, and mid- and post-training assessment sessions will be administered either via Zoom with a Helper Buddy present or through survey links sent to participants via the UIC REDCap system. The training sessions will be performed independently by the participants in the presence of a Helper Buddy. The investigators will recruit 75 people with multiple sclerosis (PwMS) for this study. Eligible participants will be randomized to either the FBI (Intervention) or stretching (Control) group, followed by an onboarding session with a designated Helper Buddy. Training will occur twice weekly for four months. Based on the anticipated attrition rate, the investigators aim for 40 PwMS to complete the post-training assessments and finish the study.

Recruiting
Has No Placebo

University of Illinois at Chicago

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials
Image of Minneapolis VA Health Care System in Minneapolis, United States.

Brain Stimulation + Cognitive Training for TBI

65+
All Sexes
Minneapolis, MN

The goal of this clinical trial is to learn if combining brain stimulation with cognitive training can improve thinking skills in older adults who have had a traumatic brain injury (TBI). The main questions are: * Does transcranial direct current stimulation (tDCS) make cognitive training more effective for improving attention, memory, and decision-making? * Is this type of home-based program feasible and acceptable for older adults with TBI? Researchers will compare two groups: one group will receive active tDCS during cognitive training, and the other group will receive sham (placebo) tDCS during cognitive training. Participants will: * Complete computer-based cognitive training exercises (BrainHQ) to practice attention, memory, and decision-making. * Receive either active or sham tDCS during training sessions. * Complete assessments before and after the program to measure changes in thinking and daily functioning.

Recruiting
New This Month

Minneapolis VA Health Care System

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials